A Randomized, Open-label Study to Characterize the Pharmacokinetics of Inhaled Oxytocin (GR121619) Compared With IM Oxytocin in Women in the Third Stage of Labour, and With IV Oxytocin in Non-pregnant, Non-lactating Women of Childbearing Potential
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Oxytocin (Primary) ; Oxytocin (Primary) ; Oxytocin (Primary)
- Indications Postpartum haemorrhage
- Focus Adverse reactions; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 09 Oct 2017 Planned End Date changed from 30 Nov 2017 to 29 Dec 2017.
- 09 Oct 2017 Planned primary completion date changed from 30 Sep 2017 to 29 Dec 2017.
- 31 Aug 2017 Planned End Date changed from 30 Sep 2017 to 30 Nov 2017.